Melbourne researchers have shown they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.
The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukaemia.
Dr Ben Shields and Dr Matt McCormack from the Walter and Eliza Hall Institute’s Cancer and Haematology division discovered that loss of the Hhex protein put the handbrake on leukaemia cell growth and division. The protein is a critical factor enabling AML cells to grow uncontrollably, a hallmark of cancer.
AML is an aggressive blood cancer that appears suddenly, grows quickly and has a poor prognosis. Existing treatments for AML are associated with serious side-effects. About three quarters of patients relapse after only a short period of treatment, with a five-year survival rate of just 24 per cent.
Dr McCormack said discovering how AML overcame normal cellular controls on growth and division was a breakthrough in the search for new therapies.
“There is an urgent need for new therapies to treat AML,” said Dr McCormack. “We showed blocking the Hhex protein could put the brakes on leukaemia growth and completely eliminate AML in preclinical models. This could be targeted by new drugs to treat AML in humans.”
He said Hhex was a particularly attractive therapeutic target because it was overproduced in leukaemia and, while essential for leukaemia cell growth, was not needed by healthy blood cells.
“Most existing treatments for AML are not cancer cell-specific, and unfortunately kill off healthy cells in the process,” Dr McCormack said.
“Hhex is only essential for the leukaemic cells, meaning we could target and treat leukaemia without toxic effects on normal cells, avoiding many of the serious side-effects that come with standard cancer treatments. We also know that most people with AML have increased levels of Hhex, often associated with adverse outcomes, further indicating it is an important target for new AML drugs.”
Dr Shields said AML cells switched off the controls that strictly manage cell growth and division. “Every cell has control genes that are activated when a cell is stressed, such as in the early stages of cancer, and stop the damaged cell from reproducing.” Dr Shields said.
While these control genes are still present in AML cells, they are switched off through a process called epigenetic modification. “Hhex works by recruiting epigenetic factors to growth control genes, effectively silencing them. This allows the leukaemia cells to reproduce and accumulate more damage, contributing to the speed of AML progression,” Dr Shields said.
Dr McCormack said drugs that inhibit epigenetic modification had been previously used to treat AML, but caused significant toxicity because their targets were also required for normal blood cell function.
“Unlike the epigenetic factors targeted previously, Hhex only regulates a small number of genes and is dispensable for normal blood cells. This gives us a rare opportunity to kill AML cells without causing many side effects,” said Dr McCormack. “We now hope to identify the critical regions of the Hhex protein that enable it to function, which will allow us to design much-needed new drugs to treat AML.”
The Latest on: Leukaemia
via Google News
The Latest on: Leukaemia
Life after leukaemia: Why Tauranga family is grateful for lessons from cancer battle
on May 19, 2019 at 10:45 am
It is ironic that Diary of A Wimpy Kid is one of Max Necklen's favourite books. The 11-year-old is anything but a wimpy kid after beating leukaemia - and he has hundreds of cancer beads to prove it. ... […]
Kate Langbroek reveals her son's battle with leukaemia encouraged her to make the move to Italy
on May 18, 2019 at 12:55 pm
Hit Network radio host Kate Langbroek reflected on how her son's battle with leukaemia encouraged her to 'feel differently' about life. Speaking to Stellar Magazine on Saturday, the 53-year-old ... […]
Nine-year-old recovering from leukaemia publishes adventure tale with help of Make-A-Wish
on May 16, 2019 at 9:09 am
A NINE-YEAR-old girl recovering from leukaemia is now a published author after the Make-A-Wish foundation and Eason teamed up to publish 200 copies of her adventure story. Lost & Found (A Bedtime ... […]
Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia
on May 15, 2019 at 11:03 pm
F. Hoffmann-La Roche Ltd / Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia . Processed and transmitted by West Corporation. ... […]
Roche: FDA approves drug combo Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia
on May 15, 2019 at 10:35 pm
ZURICH, May 16 (Reuters) - Roche said on Thursday that the U.S. Food and Drug Administration had approved a treatment using its drugs Venclexta plus Gazyva for people with previously untreated chronic ... […]
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL
on May 14, 2019 at 1:40 pm
All prices are NET prices. VAT will be added later in the checkout. Peters C, Schrappe M, von Stackelberg A, Schrauder A, Bader P, Ebell W, et al. Stem-cell transplantation in children with acute ... […]
Mum describes pregnancy 'miracle' after fearing childhood leukaemia battle had left her infertile
on May 11, 2019 at 7:12 am
A Nottinghamshire mum-of-three has spoken out about her battle with leukaemia when she was seven years old which doctors initially warned could have left her infertile. Kirsty Rigby, 29, of Chilwell, ... […]
Cancer charity founders whose son had leukaemia presented with 2019 Israel Prize
on May 10, 2019 at 7:05 am
Naftali Bennett, the outgoing education minister, with Israel Prize winners Chaim and Miri Ehrental at a ceremony on Thursday night (Photo: Flash 90) Chaim and Miri Ehrental were meeting a medical ... […]
Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells
on May 10, 2019 at 5:16 am
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in Western countries. It has recently been shown that the homogeneity of the chromatin landscape between CLL cells contrasts with the ... […]
Roman Reigns opens up about WWE fans' newfound respect after leukaemia hell
on May 10, 2019 at 3:11 am
Reigns shocked the WWE Universe last October when he revealed his diagnosis and opened up about his first battle with the terrible disease 11 years ago when he was only 22 years old. The Big Dog felt ... […]
via Bing News